Ceramide glucosyltransferase (or glucosylceramide synthase) is a glucosyltransferase enzyme involved in the production of glucocerebroside.
It is classified under EC 22.214.171.124.
It is inhibited by miglustat and eliglustat, both drugs developed for the treatment of Gaucher disease.
This transferase article is a stub. You can help Wikipedia by expanding it.